Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 15, 2013

Amakem, Bayer, GW, OncoMed, Opko

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical Amakem presents results for glaucoma treatment . . . read more Phase I OncoMed begins early-stage NSCLC trial . . . read more Phase III Opko enrolls Rayaldy SHPT-CKD trial . . . read more Filings Bayer gains Xofigo approval in EC . . . read more GW gains orphan status for epilepsy treatment . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters